Product Images Glycopyrrolate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 10 images provide visual information about the product associated with Glycopyrrolate NDC 0641-6035 by West-ward Pharmaceutical Corp., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Glycopyrrolate Structual Formula - glycopyrrolate injection usp 1
Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) 10 x 20 mL Multiple Dose Vials Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) 10 x 20 mL Multiple Dose Vials - glycopyrrolate injection usp 10
This is a description of a pharmaceutical product called Glycopyrrolate Injection, USP. It comes in a package of 10 x 20 mL vials that can be used for both IM (intramuscular) or IV (intravenous) administration. The product is used to reduce secretions in the respiratory and digestive tracts. The text also mentions that the product contains benzyl alcohol.*
West-Ward logo - glycopyrrolate injection usp 2
Glycopyrrolate Injection, USP 0.2 mg/mL 1 mL Single Dose Vial - glycopyrrolate injection usp 3
Glycopyrrolate injection, USP with a concentration of 0.2 mg/mL is used for intravenous or intramuscular administration. The dose is 1 mL and the injection contains benzyl alcohol.*
Glycopyrrolate Injection, USP 0.2 mg/mL 25 x 1 mL Single Dose Vials - glycopyrrolate injection usp 4
This is a description of a medication. The product is Glycopyrrolate injection, which is used for intravenous or intramuscular administration. It comes in single-use vials and contains 0.2mg/mL. The product is not recommended for individuals with a hypersensitivity to Benzyl Alcohol. The package contains 25 vials, and its NDC is 0641-6033-25. The has also detected various symbols and characters that indicate the product's storage conditions in Celsius.*
Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) 2 mL Single Dose Vial - glycopyrrolate injection usp 5
Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) 25 x 2 mL Single Dose Vials - glycopyrrolate injection usp 6
This is a medication with a concentration of 0.2 mg/ml, containing benzyl alcohol and suitable for IV administration in newborns. It comes in 25 single-dose vials of 2 mL each and is manufactured by West-Ward in the USA. The rest of the text is not available.*
Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) 5 mL Multiple Dose Vial - glycopyrrolate injection usp 7
Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) 25 x 5 mL Multiple Dose Vials - glycopyrrolate injection usp 8
This is a description of a medication called Glycopyrrolate Injection, USP with a concentration of 1mg/5mL (0.2mg/mL). It is available in a package containing 25 5mL multiple dose vials and is intended for intramuscular or intravenous administration. The medication contains benzyl alcohol and should not be used in newborns. The accompanying literature should be consulted for dosage information. It should be stored at controlled room temperature. The manufacturer is identified as WESTWARD, located in New Jersey, USA.*
Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) 20 mL Multiple Dose Vial - glycopyrrolate injection usp 9
The text appears to be a label for a medication called Glycopyrrolate, which is available in a 20mL multiple dose vial. The medication is specifically for intramuscular or intravenous administration and contains Benzyl Alcohol. The dosage of the medication is not provided and should be accompanied by the corresponding description. The medication should be stored at a controlled room temperature between 68°F and 77°F.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.